The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
The Pharmaceutical Frontier: Biosimilars on the Rise
A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection
A New Dawn for High-Tech Manufacturing: KJS India's Second Unit Breaks Ground in Telangana
Major Win: Delhi High Court Greenlights Dr. Reddy's for Export-Only Weight-Loss Drug Production
Navigating the Pharma Horizon: Nuvama's Top 7 Bets for a Robust Portfolio
The Tale of Two Titans: Bausch Health and Dr. Reddy's Navigate a Volatile Market
A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake
The Big Play: Dr. Reddy's Bets on a Trio of Launches to Outmaneuver US Market Erosion
India Inc Braces for Q2 Earnings Deluge: Decoding the Performance of HUL, Kotak, Dr Reddy's, and Other Market Heavyweights
Telangana's Billionaire Titans: A Look at the State's 7 Richest in 2025
Market Movers: Unpacking the Buzz Around Top Stocks Today
Neuland Labs Strengthens Board with Pharma Veteran Dr. Ravi Shankar Gopinath as Independent Director